Ligand Pharma (LGND) Tops Q4 EPS by 49c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $319.43 --0%
EPS Growth %: +24.4%
Financial Fact:
Weighted average number of common shares - basic: 20.89M
Today's EPS Names:
CRMT, PKE, HELE, More
EPS Growth %: +24.4%
Financial Fact:
Weighted average number of common shares - basic: 20.89M
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q4 EPS of $1.36, $0.49 better than the analyst estimate of $0.87. Revenue for the quarter came in at $50.38 million versus the consensus estimate of $44.09 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
- Jones Trading Starts Pershing Square Inc (PS) at Buy
- JPMorgan Upgrades Wanhua Chemical Group (600309:CH) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
